Estheticare collaborates with Getz Pharma, Dr Uzair Khan paves the way

In a significant step forward for Pakistan's Aesthetic and Healthcare sector, Estheticare Clinic and pharmaceutical giant Getz Pharma have joined forces in a strategic alliance to raise awareness about Tirzepatide, a revolutionary treatment for obesity and type 2 diabetes. Drug administration of Trizpetide has been recently approved by the Drug Regulatory Authority of Pakistan.

This collaborative initiative, spearheaded by Dr. Uzair Khan, founder and CEO of Estheticare Clinic, marks an important milestone in bringing world-class metabolic health solutions to Islamabad, Pakistan.

A strategic healthcare alliance

This partnership represents a joint venture between two industry leaders—Getz Pharma's pharmaceutical excellence and Estheticare's clinical innovation—working together to educate healthcare professionals and the public about this groundbreaking treatment option. The collaboration aims to ensure that Pakistani patients have access to comprehensive information and quality care when considering Tirzepatide therapy.

Understanding Tirzepatide: A dual-action breakthrough

The active pharmaceutical ingredient Tirzepatide is internationally recognized and marketed globally by the brand name Mounjaro (and Zepbound for weight management). This dual GIP/GLP-1 receptor agonist is now also available in Pakistan under the local brand name TIRZEE™, launched by Getz Pharma, providing a locally manufactured and more accessible option of the same drug for patients managing type 2 diabetes and obesity across the country.

Tirzepatide represents a revolutionary approach to treating obesity and type 2 diabetes. This once-weekly injection works as a dual agonist, simultaneously targeting two critical hormone receptors:

GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor

GLP-1 (Glucagon-Like Peptide-1) receptor

This dual-action mechanism sets Tirzepatide apart from previous treatments, offering enhanced efficacy in managing blood sugar levels, promoting weight loss, and improving overall metabolic health.

Flexible dosing options

The treatment is available in four carefully calibrated doses to accommodate individual patient needs:

2.5mg – Initial starting dose

5mg – Progressive treatment level

7.5mg – Advanced therapeutic dose

10mg – Maximum maintenance dose

This graduated dosing approach allows Dr. Khan and his team at Estheticare to personalize treatment protocols using their AI-powered systems, ensuring optimal results while minimizing side effects for each patient.

The Getz Pharma team

Getz Pharma's dedicated team of professionals led the awareness initiative:

Syed Tabish Naseem

Muhammad Shahzeb Ashraf

Uzair Farooq

Zain Latif

Shehreen Sharafat

These representatives worked collaboratively with Estheticare to ensure comprehensive education about Tirzepatide reaches healthcare providers and patients across Pakistan.

Dr. Uzair Khan's vision for comprehensive wellness

Dr. Uzair Khan's participation in this awareness initiative reflects Estheticare's commitment to holistic health and wellness. Known for pioneering AI-integrated aesthetic medicine in Pakistan, Dr. Khan recognizes the importance of addressing metabolic health as part of comprehensive patient care.

"This collaboration with Getz Pharma allows us to educate our community about advanced treatment options that can genuinely transform lives," the initiative emphasizes. "By working together, we can ensure Pakistani patients have access to information about world-class therapies."

The estheticare advantage

Patients receiving Tirzepatide treatment at Estheticare will benefit from:

AI-Powered Personalization: Estheticare's advanced systems will analyze patient data to optimize dosing schedules and predict treatment outcomes

Comprehensive Monitoring: Regular assessments using FDA-approved equipment to track progress and adjust protocols

Integrated Care: Combination with nutritional guidance, lifestyle counseling, and complementary wellness treatments

Luxury Experience: Treatment delivered in Estheticare's boutique clinic environment, complete with an in-house restaurant and premium hospitality

Addressing Pakistan's health crisis

The introduction of Tirzepatide comes at a critical time for Pakistan, where diabetes and obesity rates have been rising steadily. This collaboration between Estheticare and Getz Pharma provides a powerful new tool in addressing these interconnected health challenges.

The regulatory approval by Pakistani authorities demonstrates the regulatory authority’s commitment to bringing innovative treatments to local patients, eliminating the need for medical tourism and making advanced therapies accessible within the country.

Expert insight: The mind-body connection

Adding a psychological perspective to the discussion, Sports Psychologist and Emotional Wellness Coach Mohsin Nawaz emphasizes that obesity is not merely a physical concern but a deeply emotional one.

 “When a person carries excess weight, it doesn’t just weigh down the body—it burdens the mind,” says Nawaz. “Sustained obesity often leads to lowered self-esteem, fatigue, and emotional withdrawal. Losing weight, therefore, is not just about appearance; it’s about reclaiming confidence, energy, and a sense of control over one’s life. True wellness begins when the mind and body start healing together.”

His perspective highlights how treatments like Tirzepatide can become catalysts for both physical transformation and emotional empowerment.

International recognition

The participation of international delegates at the launch event underscores the global significance of this partnership. It positions Pakistan as an emerging hub for advanced medical treatments and demonstrates the country's capacity to adopt and deliver cutting-edge healthcare solutions.

The future of aesthetic & metabolic health in Pakistan

This collaboration between Estheticare and Getz Pharma sets a new precedent for public-private partnerships in Pakistan's healthcare sector. By combining pharmaceutical innovation with clinical excellence and technological sophistication, they're creating a model that other institutions may follow.

For patients struggling with obesity and diabetes, Tirzepatide represents hope—a scientifically proven treatment that can help them achieve significant weight loss, improve glycemic control, and enhance their overall quality of life.

Availability and access

Tirzepatide is now available at Estheticare Clinic in Islamabad, where Dr. Khan's expert team provides comprehensive consultations to determine patient eligibility and develop customized treatment plans.